Page last updated: 2024-09-04

atractylenolide iii and Alveolitis, Fibrosing

atractylenolide iii has been researched along with Alveolitis, Fibrosing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ding, J; Huai, B	1

Other Studies

1 other study(ies) available for atractylenolide iii and Alveolitis, Fibrosing

Article	Year
Atractylenolide III attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2/NQO1/HO-1 pathway activation. Immunopharmacology and immunotoxicology, 2020, Volume: 42, Issue:5 Topics: Animals; Antioxidants; Apoptosis; Bleomycin; Disease Models, Animal; Heme Oxygenase (Decyclizing); Lactones; Lung; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Pulmonary Fibrosis; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction	2020

Article

Year

Atractylenolide III attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2/NQO1/HO-1 pathway activation.

Immunopharmacology and immunotoxicology, 2020, Volume: 42, Issue:5

Topics: Animals; Antioxidants; Apoptosis; Bleomycin; Disease Models, Animal; Heme Oxygenase (Decyclizing); Lactones; Lung; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Pulmonary Fibrosis; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction

2020